(Q40657305)

22 September 2017

1 reference

title

Multidisciplinary management of advanced primary and metastatic breast cancer (English)

1 reference

22 September 2017

metastatic breast cancer

1 reference

Hortobagyi GN

1

1 reference

PubMed ID

8004615

22 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

22 September 2017

1 reference

22 September 2017

74

1 reference

22 September 2017

1 Suppl

1 reference

22 September 2017

416-423

1 reference

Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Combined chemotherapy and radiotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Multimodal treatment of locoregionally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Concurrent chemotherapy and radiotherapy for nonmetastatic, Stage IV breast cancer. A pilot study by the Southeastern Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Results of combined treatment of patients with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

T3b-T4 breast cancer: factors affecting results in combined modality treatments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

An analysis of the role of radiotherapy alone and in combination with chemotherapy and surgery in the management of advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Inflammatory breast carcinoma treated by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Initial chemoimmunotherapy in inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Aggressive combined modality therapy for advanced local-regional breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Management of inflammatory carcinoma of the breast. A combined modality approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Current status of endocrine treatment of carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Overview of new treatments for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Monoclonal antibodies in diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.2820741329

7 January 2021

Identifiers

DOI

10.1002/CNCR.2820741329

0 references

PubMed ID

8004615

1 reference

PubMed ID

8004615